JPH0525476B2 - - Google Patents
Info
- Publication number
- JPH0525476B2 JPH0525476B2 JP57150357A JP15035782A JPH0525476B2 JP H0525476 B2 JPH0525476 B2 JP H0525476B2 JP 57150357 A JP57150357 A JP 57150357A JP 15035782 A JP15035782 A JP 15035782A JP H0525476 B2 JPH0525476 B2 JP H0525476B2
- Authority
- JP
- Japan
- Prior art keywords
- tryptophan
- genus
- indole
- culture
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 35
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 24
- 229960004799 tryptophan Drugs 0.000 claims description 18
- 238000004519 manufacturing process Methods 0.000 claims description 15
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 12
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 12
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 11
- 229960001153 serine Drugs 0.000 claims description 8
- 241000186146 Brevibacterium Species 0.000 claims description 6
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 238000006911 enzymatic reaction Methods 0.000 claims description 5
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 claims description 3
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 claims description 3
- 229960001327 pyridoxal phosphate Drugs 0.000 claims description 3
- 229940076263 indole Drugs 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 238000000034 method Methods 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 230000001580 bacterial effect Effects 0.000 description 9
- 244000005700 microbiome Species 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 241000590020 Achromobacter Species 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 235000013882 gravy Nutrition 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- JTWUZULPZAALRN-UHFFFAOYSA-N 3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carbaldehyde;phosphoric acid Chemical compound OP(O)(O)=O.CC1=NC=C(CO)C(C=O)=C1O JTWUZULPZAALRN-UHFFFAOYSA-N 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000186145 Corynebacterium ammoniagenes Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000221960 Neurospora Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 241000319304 [Brevibacterium] flavum Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- CEQFOVLGLXCDCX-WUKNDPDISA-N methyl red Chemical compound C1=CC(N(C)C)=CC=C1\N=N\C1=CC=CC=C1C(O)=O CEQFOVLGLXCDCX-WUKNDPDISA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000019086 sulfide ion homeostasis Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- SPOMEWBVWWDQBC-UHFFFAOYSA-K tripotassium;dihydrogen phosphate;hydrogen phosphate Chemical compound [K+].[K+].[K+].OP(O)([O-])=O.OP([O-])([O-])=O SPOMEWBVWWDQBC-UHFFFAOYSA-K 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
【発明の詳細な説明】
本発明は、L−トリプトフアンの製造法に関
し、更に詳しくは、特定の微生物菌体を用いた酵
素法によるL−トリプトフアンの製造法に関す
る。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing L-tryptophan, and more particularly to a method for producing L-tryptophan by an enzymatic method using specific microbial cells.
次式():
で示されるL−トリプトフアンは、栄養上欠くこ
とのできない必須アミノ酸の一つとして、発育、
成長、体重保持、体脂肪保持、血球成分造成、乳
汁分泌等に重要な役割を果たし、生命維持に欠か
せないものであり、医薬、栄養源又は動物飼料の
添加物として、広く利用されている重要なアミノ
酸である。 The following formula (): L-tryptophan, represented by
It plays an important role in growth, weight retention, body fat retention, blood cell component formation, milk secretion, etc., and is essential for life support, and is widely used as an additive in medicines, nutritional sources, and animal feed. It is an important amino acid.
L−トリプトフアンの製造法としては、化学的
合成法又は生化学的製法の種々の方法が知られて
いる。 Various chemical synthesis methods and biochemical production methods are known as methods for producing L-tryptophan.
化学的合成法は、大量生産には適するが、得ら
れるトリプトフアンがDL−体であるため光学分
割を行なわねばならないという欠点を有する。 Although the chemical synthesis method is suitable for mass production, it has the disadvantage that the tryptophan obtained is in the DL-form and optical resolution must be carried out.
生化学的製法のうち、微生物を利用する方法と
しては、直接発酵法により糖質を用いてL−トリ
プトフアンを生成・蓄積させる方法及びインドー
ル又はアントラニル酸を添加して微生物を培養
し、培養液中にL−トリプトフアンを生成・蓄積
させる前駆体発酵法がある。 Among biochemical production methods, methods using microorganisms include direct fermentation methods to produce and accumulate L-tryptophan using carbohydrates, and methods in which microorganisms are cultured by adding indole or anthranilic acid to the culture solution. There is a precursor fermentation method that produces and accumulates L-tryptophan.
一方、酵素法としては、インドールとセリン;
又はインドールとピルビン酸及びアンモニウムイ
オンからL−トリプトフアンを製造する方法があ
る。この酵素法は、化学的合成法により製造され
る安価な原料を用いる製法であり、工業的に有力
なものとして期待されているが、酵素の安価なる
製造法の開発が望まれている。 On the other hand, as an enzymatic method, indole and serine;
Alternatively, there is a method for producing L-tryptophan from indole, pyruvic acid, and ammonium ion. This enzymatic method uses inexpensive raw materials produced by chemical synthesis, and is expected to be an industrially powerful method, but there is a desire to develop an inexpensive method for producing enzymes.
従来、酵素作用によりL−トリプトフアンを製
造する方法には、エシエリキア属(Genus
Escherichia)、プロテウス属(Genus Proteus)、
シユードモナス属(Genus Pseudomonas)、ア
エロバクター層(Genus Aerobacter)又はエル
ビニア層(Genus Erwinia)に属する微生物を
用いる方法(特公昭49−46917号);エシエリキア
属、クラビセプツ属(Genus Claviceps)、ノイ
ロスポラ属(Genus Neurospora)、サツカロマ
イセス属(Genus Saccharomyces)、バチルス属
(Genus Bacillus)、アクロモバクター属(Genus
Achromobacter)又はアルカリゲネス属
(Genus Alcaligenes)に属する微生物を用いる
方法(フランス特許第1207437号、特開昭47−
39693号、特公昭53−1836号)等が知られている。 Conventionally, methods for producing L-tryptophan by enzymatic action include
Escherichia), Genus Proteus,
A method using microorganisms belonging to the genus Pseudomonas, Genus Aerobacter, or Genus Erwinia (Special Publication No. 46917/1987); Neurospora), Genus Saccharomyces, Genus Bacillus, Achromobacter (Genus
A method using microorganisms belonging to the genus Achromobacter or Genus Alcaligenes (French Patent No. 1207437, Japanese Patent Application Laid-Open No. 1983-1998)
39693, Special Publication No. 53-1836), etc. are known.
しかしながら、ブレビバクテリウム属(Genus
Brevibacterium)に属する微生物を利用する方
法は知られていない。従来、ブレビバクテリウム
属に属する微生物を利用することにより、インド
ールから変換された物質としては、ブレビバクテ
リウム・アンモニアゲネスを用いる場合に得られ
るL−メトキシトリプトフアン(特公昭52−8400
号)が知られているのみである。 However, Brevibacterium (Genus
There is no known method to utilize microorganisms belonging to the genus Brevibacterium. Conventionally, a substance converted from indole using a microorganism belonging to the genus Brevibacterium is L-methoxytryptophan (Japanese Patent Publication No. 52-8400) obtained when Brevibacterium ammoniagenes is used.
(No.) is only known.
本発明者らは、
次式():
で示されるインドールと、
次式():
で示されるセリンとから、前記式()で示され
るL−トリプトフアンを生産する能力を有する微
生物を広く探索した結果、好収率でL−トリプト
フアンを生産するブレビバクテリウム属に属する
微生物を見出し、これを利用することにより本発
明を完成するに至つた。 The inventors have the following formula (): Indole denoted by and the following formula (): As a result of a wide search for microorganisms that have the ability to produce L-tryptophan represented by the above formula () from serine represented by By utilizing this, we have completed the present invention.
即ち、本発明のL−トリプトフアンの製造法
は、インドール、L−セリン及びピリドキサール
リン酸を含有する水溶液にブレビバクテリウム・
フラバムMJ−233菌体又はそれから得られた酵素
を作用させ、酵素法によりL−トリプトフアンを
製造する方法である。 That is, in the method for producing L-tryptophan of the present invention, Brevibacterium spp.
This is a method for producing L-tryptophan by an enzymatic method by using Flavum MJ-233 cells or an enzyme obtained therefrom.
本発明に利用される微生物は、ブレビバクテリ
ウム属に属し、かつ、インドールとセリンとから
L−トリプトフアンを生産する能力を有するブレ
ビバクテリウム・フラバム(Brevibacterium
flavum)MJ−233(微工研条寄第1479号;特開昭
51−130592号)である。その菌学的性質を以下に
示す。 The microorganism used in the present invention belongs to the genus Brevibacterium and has the ability to produce L-tryptophan from indole and serine.
flavum) MJ-233 (Microtechnical Research Institute No. 1479; JP-A-Sho
51-130592). Its mycological properties are shown below.
菌学的性質
0.6〜0.8×1.0×2.4μの短桿菌。通常V字形の
対をなし、柵状も認められる。グラム陽性、無
胞子、非運動性、夾膜認められず、非抗酸性。Mycological properties: Short rods measuring 0.6-0.8 x 1.0 x 2.4μ. They usually form a V-shaped pair, and fence-like patterns are also recognized. Gram-positive, non-sporulating, non-motile, no capsule, non-acid fast.
培養的性質
1 肉汁寒天コロニー
円形、表面は平滑、コロニーの隆起は扁平
もしくはやゝ隆起、コロニーの周縁はやゝ波
状、黄色、不透明、やゝ光沢あり。 Cultural properties 1. Juicy agar colony: round, the surface is smooth, the ridges of the colony are flat or slightly ridged, the periphery of the colony is slightly wavy, yellow, opaque, and slightly glossy.
2 肉汁寒天傾面 生育中程度、糸状、黄色。 2 Gravy agar slope Medium growth, filamentous, yellow.
3 肉汁 生育中程度、沈渣あり、濁度なし。 3 Gravy Medium growth, sediment, no turbidity.
4 肉汁寒天穿刺 表面によく生育、内部生育は僅かで糸状。 4 Meat juice agar puncture It grows well on the surface, and the internal growth is sparse and filamentous.
生育条件 1 生育温度:適温30〜37℃、範囲15〜40℃ 2 生育PH:最適PH7〜8、範囲5〜10 3 酸素要求性:好気性 4 アンモニウム塩の利用性:あり、 5 尿素の利用性:あり 6 硝酸塩の利用性:あり 生理学的性質 その他 1 ゼラチンを液化しない。 Growing conditions 1 Growth temperature: Suitable temperature 30-37℃, range 15-40℃ 2 Growth PH: Optimal PH7-8, range 5-10 3 Oxygen requirement: aerobic 4 Utilization of ammonium salt: Yes, 5 Usability of urea: Yes 6 Availability of nitrate: Yes Physiological properties Other 1 Do not liquefy gelatin.
2 リトマスミルク変化しない。2 Litmus milk does not change.
3 硝酸塩の還元性:陽性
4 インドールの生成:陰性
5 硫化水素の生成:陰性
6 澱粉の加水分解:陰性
7 ペプトンからアンモニアの生成:陽性
8 フオーゲスプロスカウエル反応:陰性
9 メチルレツド試験:陽性(弱)
10 カタラーゼ:陽性
11 ウレアーゼ:陽性
12 炭水化物から酸の生産
グルコース、サツカロース、トレハロー
ス、マルトース、サリシンから酸を生成、ガ
スは生成しない。アラビノース、キシロー
ス、ラクトース、ラムノース、ラフイノー
ス、マンニツト、ズルシツト、イノシツト、
アドニツトから酸及びガスを生成しない。3 Reducibility of nitrate: Positive 4 Indole production: Negative 5 Hydrogen sulfide production: Negative 6 Starch hydrolysis: Negative 7 Ammonia production from peptone: Positive 8 Vougesproskauer reaction: Negative 9 Methylred test: Positive (weak) ) 10 Catalase: Positive 11 Urease: Positive 12 Production of acid from carbohydrates Acid is produced from glucose, sutucarose, trehalose, maltose, and salicin, but no gas is produced. Arabinose, xylose, lactose, rhamnose, raffinose, mannite, zulcitrate, inosito,
Adonis does not produce acids or gases.
13 ビタミンの要求性:ビオチンの要求性あ
り。 13 Vitamin requirement: Biotin requirement.
本菌株の培養に使用する培地はエタノールを主
炭素源とし、窒素源、無機塩は普通に用いられる
ものでよい。即ち、窒素源としてはアンモニア、
硫酸アンモニウム、塩化アンモニウム、尿素等を
単独でもしくは混合し使用する。無機塩としては
燐酸一水素カリウム、燐酸二水素カリウム、硫酸
マグネシウム等が用いられる。この他にペプト
ン、肉エキス、酵母エキス、コーンステイープリ
カー、カザミノ酸、各種ビタミン等の栄養素も菌
の生育に必要な量で使用される。 The medium used for culturing this strain uses ethanol as the main carbon source, and commonly used nitrogen sources and inorganic salts may be used. That is, ammonia as a nitrogen source,
Ammonium sulfate, ammonium chloride, urea, etc. are used alone or in combination. As the inorganic salt, potassium monohydrogen phosphate, potassium dihydrogen phosphate, magnesium sulfate, etc. are used. In addition, nutrients such as peptone, meat extract, yeast extract, cornstarch liquor, casamino acids, and various vitamins are also used in amounts necessary for the growth of the bacteria.
培養は通気撹拌培養、振盪培養等の好気的条件
下で行ない、培養温度は20〜40℃、好ましくは25
〜30℃である。培養中のPHは5〜10、好ましくは
中性付近に保つ。培養中のPHの調節は、酸又はア
ルカリを適宜添加することにより行なうことがで
きる。培養開始時のエタノール濃度は、1〜5容
量%、好ましくは3〜4容量%とする。このよう
に、エタノールを比較的高濃度とすることによ
り、所謂、雑菌による汚染を効率よく防止するこ
とができる。 Cultivation is performed under aerobic conditions such as aerated stirring culture or shaking culture, and the culture temperature is 20 to 40°C, preferably 25°C.
~30℃. The pH during culturing is maintained at 5 to 10, preferably around neutral. The pH during culture can be adjusted by adding acid or alkali as appropriate. The ethanol concentration at the start of culture is 1 to 5% by volume, preferably 3 to 4% by volume. In this way, by using ethanol at a relatively high concentration, so-called contamination by various germs can be efficiently prevented.
培養期間は1〜8日間、好ましくは1〜3日間
である。 The culture period is 1 to 8 days, preferably 1 to 3 days.
本菌株を用いてL−トリプトフアンを製造する
際には、前記の如く培養して得た培養物(培養生
産物)、該培養物を遠心法等により分離して得ら
れる菌体又は該菌体の処理物、例えば洗浄菌体、
乾燥菌体、菌体破壊物、固定化菌体等の種々の形
態の菌体が使用される。また、前記種々の形態の
菌体を抽出・精製して得た酵素又は該酵素をビニ
ル系重合体系に固定化した固定化酵素を使用して
もよい。 When producing L-tryptophan using this strain, the culture obtained by culturing as described above (culture product), the bacterial cells obtained by separating the culture by centrifugation, or the bacterial cells processed materials, such as washed bacterial cells,
Various forms of bacterial cells are used, such as dried bacterial cells, destroyed bacterial cells, and immobilized bacterial cells. Furthermore, enzymes obtained by extracting and purifying the various forms of bacterial cells described above or immobilized enzymes obtained by immobilizing the enzymes on a vinyl polymer system may also be used.
基質であるインドールの反応液中の濃度は、特
に制限はないが、好ましくは0.1〜15w/v%で
あり、セリンの反応液中の濃度も同様に特に制限
はないが、好ましくは0.1〜15w/v%である。 The concentration of the substrate indole in the reaction solution is not particularly limited, but is preferably 0.1 to 15 w/v%, and the concentration of serine in the reaction solution is similarly not limited, but is preferably 0.1 to 15 w/v%. /v%.
反応液には、基質であるインドール、セリンの
他に、L−トリプトフアンの生成率を高めるため
にピリドキサールリン酸を添加せしめることが好
ましい。 In addition to the substrates indole and serine, pyridoxal phosphoric acid is preferably added to the reaction solution in order to increase the production rate of L-tryptophan.
溶媒としては、一般には、水が用いられ、必要
に応じてトリトンX−100(ポリオキシエチレンア
ルキルフエノールエーテル系非イオン性界面活性
剤)、トウイ−ン20(ポリオキシエチレンソルビタ
ンモノラウレイト系非イオン性界面活性剤)等の
界面活性剤を添加することが好ましい。 Water is generally used as a solvent, and if necessary, Triton It is preferable to add a surfactant such as ionic surfactant).
反応液中のPHは、通常5〜12であり、反応温度
は15〜60℃であることが好ましい。 The pH in the reaction solution is usually 5 to 12, and the reaction temperature is preferably 15 to 60°C.
以上の条件に従い処理することにより、目的と
するL−トリプトフアンを、効率よく、かつ、安
価に得ることができる。得られたL−トリプトフ
アンの分離・精製は、通常のイオン交換樹脂法や
その他の公知の方法を組み合わせることにより、
容易に行なうことができる。 By processing according to the above conditions, the target L-tryptophan can be obtained efficiently and at low cost. The obtained L-tryptophan can be separated and purified by combining the usual ion exchange resin method and other known methods.
It can be done easily.
以下、実施例により、本発明を更に詳細に説明
するが、これらの実施例は、本発明の範囲を何ら
制限するものではない。 EXAMPLES Hereinafter, the present invention will be explained in more detail with reference to Examples, but these Examples are not intended to limit the scope of the present invention in any way.
実施例 1
以下の表に示した培地(エタノールを除く)10
mlを直径24mmの試験管に分注し、120℃、15分間
滅菌処理し、次に無菌条件下に2v/v%エタノ
ールを加え、ブレビバクテリウム・フラバムMJ
−233を1白金耳接種し、30℃で20時間振盪培養
し前培養液とした。次に同様に調製した培地50ml
を500ml容量の三角フラスコに入れ、120℃、15分
間滅菌処理した後、2v/v%のエタノールを加
えた培地に前培養液2.5mlを接種して、30℃にて
20時間振盪培養した。Example 1 Medium shown in the table below (excluding ethanol)10
Dispense ml into test tubes with a diameter of 24 mm, sterilize at 120°C for 15 minutes, then add 2 v/v% ethanol under aseptic conditions to remove Brevibacterium flavum MJ.
-233 was inoculated with one platinum loop and cultured with shaking at 30°C for 20 hours to obtain a preculture solution. Next, 50ml of medium prepared in the same way
was placed in a 500 ml Erlenmeyer flask and sterilized at 120°C for 15 minutes, then 2.5 ml of the preculture was inoculated into a medium containing 2v/v% ethanol, and incubated at 30°C.
It was cultured with shaking for 20 hours.
培養終了後、遠心分離により集菌し、100mM
リン酸緩衝液にて洗菌し、これをインドール1.0
g、L−セリン1.2g、ピリドキサールリン酸10
mg、トリトンX−100 5ml、水95ml(PH8.5)の
組成からなる反応液10mlに懸濁し、撹拌しながら
30℃にて17時間反応を行なつた。反応液を直ちに
遠心分離して得た上澄液中にL−トリプトフアン
16g/の生成が認められた。 After culturing, collect the bacteria by centrifugation and dilute to 100mM.
Wash with phosphate buffer and add indole 1.0
g, L-serine 1.2 g, pyridoxal phosphate 10
mg, 5 ml of Triton X-100, and 95 ml of water (PH8.5).
The reaction was carried out at 30°C for 17 hours. The reaction solution was immediately centrifuged, and L-tryptophan was added to the supernatant obtained.
Production of 16g/was observed.
実施例 2
実施例1と同様にして得た洗浄菌体を、インド
ール1.0g、L−セリン1.2g、ピリドキサールリ
ン酸10mg、トウイーン20 5ml、水95ml(PH8.5)
の組成からなる反応液10mlに懸濁して、30℃で17
時間撹拌しながら反応を行なつた。反応液を直ち
に遠心分離して得た上澄液中にL−トリプトフア
ン15g/の生成が認められた。Example 2 Washed bacterial cells obtained in the same manner as in Example 1 were mixed with 1.0 g of indole, 1.2 g of L-serine, 10 mg of pyridoxal phosphate, 5 ml of Tween 20, and 95 ml of water (PH8.5).
Suspend in 10 ml of a reaction solution with the composition of
The reaction was carried out with stirring for hours. The reaction solution was immediately centrifuged, and 15 g/L-tryptophan was observed to be produced in the supernatant obtained.
表 培地組成 尿 素 2.0g 硫酸アンモニウム 7.0g KH2PO4 K2HPO4 MgSO4・7H2O 各0.5g FeSO4・7H2O MnSO4・4〜6H2O CaCl2・2H2O NaCl ZnSO4・7H2O 各2 mg 酵母エキス 0.5g カザミノ酸 0.5g 水 1 Table medium composition Urea 2.0g Ammonium sulfate 7.0g KH 2 PO 4 K 2 HPO 4 MgSO 4・7H 2 O 0.5g each FeSO 4・7H 2 O MnSO 4・4~6H 2 O CaCl 2・2H 2 O NaCl ZnSO 4・7H 2 O 2 mg each Yeast extract 0.5g Casamino acids 0.5g Water 1
Claims (1)
リン酸を含有する水溶液にブレビバクテリウム・
フラバムMJ−233菌体又はそれから得られた酵素
を作用させ、酵素法によりL−トリプトフアンを
製造する方法。1. In an aqueous solution containing indole, L-serine and pyridoxal phosphate, Brevibacterium
A method for producing L-tryptophan by an enzymatic method by reacting Flavum MJ-233 cells or an enzyme obtained therefrom.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15035782A JPS5939296A (en) | 1982-08-30 | 1982-08-30 | Preparation of l-tryptophan using bacterium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15035782A JPS5939296A (en) | 1982-08-30 | 1982-08-30 | Preparation of l-tryptophan using bacterium |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5939296A JPS5939296A (en) | 1984-03-03 |
JPH0525476B2 true JPH0525476B2 (en) | 1993-04-13 |
Family
ID=15495215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP15035782A Granted JPS5939296A (en) | 1982-08-30 | 1982-08-30 | Preparation of l-tryptophan using bacterium |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5939296A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61111698A (en) * | 1984-11-02 | 1986-05-29 | Shoichi Shimizu | Production of tryptophan |
JPH044531Y2 (en) * | 1985-09-18 | 1992-02-10 |
-
1982
- 1982-08-30 JP JP15035782A patent/JPS5939296A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5939296A (en) | 1984-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4529697A (en) | Process for producing L-glutamic acid by fermentation | |
JP4197754B2 (en) | Method for producing lactic acid or succinic acid | |
Tsugawa et al. | Production of l-Glutamic Acid from dl-Hydantoin-5-propionic Acid by Microoganisms: Part I. Screening of l-Glutamic Acid-Producing Microorganisms and Some Optimal Conditions for Production of l-Glutamic Acid | |
JPS62289A (en) | Enzymatic production of l-alpha-amino acid from alpha-ketoic acid | |
JPH0525476B2 (en) | ||
JPH0440899A (en) | Biological production of alpha-hydroxy-4-methylthiobutyramide | |
JPH0355116B2 (en) | ||
JP3122990B2 (en) | Process for producing O-methyl-L-tyrosine and L-3- (1-naphthyl) alanine | |
EP0295622B1 (en) | Process for producing l-tryptophan | |
US3310475A (en) | Method for producing l-aspartic acid | |
JPS6117475B2 (en) | ||
JP2676741B2 (en) | New microorganism | |
JPH05176794A (en) | Production of optically active 2-phenylpropionic acid and 2-phenylpropionamide | |
JP2899071B2 (en) | Method for producing L-α-alanine | |
JPH0582199B2 (en) | ||
JPS62296895A (en) | Production of l-isoleucine from d, l-alpha-hydroxybutyrate and variant of corynebacterium glutamicum | |
JPH11341979A (en) | Production of bacterial cell body having high nitrilase productivity | |
JPS6142556B2 (en) | ||
JPH0665313B2 (en) | Method for producing trans-4-cyanocyclohexane-1-carboxylic acid | |
JPH0346115B2 (en) | ||
JPH0355115B2 (en) | ||
JPS62289194A (en) | Production of phenylalanine or its derivative | |
JPH0424992B2 (en) | ||
JPH0464674B2 (en) | ||
JPH02295491A (en) | Preparation of l-isoleucine |